Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic...
PCI Pharma Services Announces Major Investment to Expand Development and Manufacturing Capabilities at Tredegar,...
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced it...
Spotlight on Abzena’s Developability Platform during Antibody Engineering & Therapeutics 2019
Abzena is showcasing its new Developability Service, enabling biotechnology and pharmaceutical companies to improve lead...
Big pharma agrees to drastically cut prices of blockbuster drugs in China
China’s National Healthcare Security Administration (NHSA) has announced it has agreed an average 61% cut...
FDA approves Aleors Diclofenac sodium topical solution
The US Food and Drug Administration (FDA) has granted tentative approval for Aleor Dermaceuticals’ Diclofenac...
Aptar Pharma, Platinum Sponsor at DDL 2019, to Showcase Expanded Portfolio of Respiratory Innovations...
Aptar Pharma, a leading drug delivery systems provider, announces its Platinum Sponsorship of this year’s...
Chi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for Pancreatic Neuroendocrine Tumors
Hutchison China MediTech Limited announces that the U.S. FDA has granted Orphan Drug designation to...
Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases
Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, announced...
DuPont Reveals Enhanced Application and Innovation Center, Increased Production Capacity at CPhI India
DuPont Nutrition & Biosciences has consistently advanced its customers forward by ensuring global access to...
Dicerna, Novo Nordisk sign RNAi deal for liver-related cardio-metabolic diseases
US-based Dicerna Pharmaceuticals and Novo Nordisk have signed a deal worth up to around $607m...
